SCHEMBL26050356

SCHEMBL26050356

Clc1ccc(-c2ccc3c(c2)C(c2ccccc2)(c2ccccc2)c2cc(Br)ccc2-3)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 5/20 0.46
CYP1A2 P05177 1/20 0.40
TDP2 O95551 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
MCL1 Q07820 2/20 0.36
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
CTRC Q99895 1/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257780 1.00 PDK2 (0.46) PDK2CYP1A2TDP2ALDH1A1MAPK1
SCHEMBL26050362 0.93 PDK2 (0.41) PDK2CYP1A2TDP2ALDH1A1MAPK1
SCHEMBL12781938 0.91 MAPK1 (0.45) PDK2TDP2ALDH1A1MAPK1MCL1
SCHEMBL16922981 0.91 MAPK1 (0.45) PDK2TDP2ALDH1A1MAPK1MCL1
SCHEMBL5359737 0.89 PDK2 (0.38) PDK2CYP1A2TDP2ALDH1A1MCL1
SCHEMBL15678833 0.88 MAPK1 (0.42) PDK2TDP2ALDH1A1MAPK1MCL1
SCHEMBL16922978 0.88 MAPK1 (0.45) PDK2TDP2ALDH1A1MAPK1MCL1
SCHEMBL20690840 0.88 PDK2 (0.41) PDK2LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL30233610 0.88 PDK2 (0.41) PDK2LMNAMAPTKMT2ASMN1; SMN2
SCHEMBL12781961 0.88 ALDH1A1 (0.48) PDK2TDP2ALDH1A1MAPK1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230271989-A1 METAL COMPLEXES UDC IRELAND LIMITED (IE) 2023-08-31 US disclosed
US-20230271989-A1 METAL COMPLEXES UDC IRELAND LIMITED (IE) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271989-A1 METAL COMPLEXES AP3M1, AP1M1, AP2M1 PDK2 1385/4885CYP1A2 4158/4885TDP2 2702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.